UM

Browse/Search Results:  1-1 of 1 Help

Selected(0)Clear Items/Page:    Sort:
2022 update on the scientific premise and clinical trials for IL-15 agonists as cancer immunotherapy Journal article
Yingjun Peng, Shengyu Fu. 2022 update on the scientific premise and clinical trials for IL-15 agonists as cancer immunotherapy[J]. Journal of Leukocyte Biology, 2022, 112(4), 823-834.
Authors:  Yingjun Peng;  Shengyu Fu
Favorite | TC[WOS]:8 TC[Scopus]:8  IF:3.6/5.2 | Submit date:2022/08/05
Cytokine  Il-15  Il-2  Immunotherapy  Protein Engineering